OpenCharities

EOS Network - Eosinophilic Diseases Charity

Eos Network, EOS Network, EOS Network - Eosinophilic Diseases Charity

Country
England & Wales
Charity number
1198883
Status
Registered
Registered
May 10, 2022
Legal form
CIO

Address

Address
Alpenrose
Weeley Road
Great Bentley
COLCHESTER
Essex
CO7 8PD

Contact

Activities

We provide evidence-based information and support for people with Eosinophilic Associated Diseases, their families and carers; a global platform for clinicians and researchers to connect; and educational resources and events for healthcare professionals. We work with our communities, medical bodies, manufacturers, and funders to improve healthcare services by ensuring the patient's voice is heard.

Objects: The Relief Of Sickness And The Preservation Of Health Among People With Eosinophilic Associated Diseases, And By Extension Their Families And Carers, In Particular But Not Exclusively By: (A) Advancing The Education Of The General Public And The Medical Profession In All Areas Relating To Eosinophilic Associated Diseases; (B) Providing Relief To And Promoting The Good Physical And Mental Health Of Persons Diagnosed With Eosinophilic Associated Diseases, And By Extension Their Families And Carers Through A Community Hub And The Provision Of Resources, Advice, Guidance And Events; And (C) Funding, Sharing And Cooperating With National And International Organisations To Support Medical Research Into The Causes, Treatment And Cure Of Eosinophilic Associated Diseases.

Classification

How
Provides Services, Provides Advocacy/advice/information
What
The Advancement Of Health Or Saving Of Lives
Who
Children/young People, Elderly/old People, People With Disabilities

Areas of operation

Region
Throughout England And Wales

Finances

Period end Income Expenditure
March 31, 2025 £204,479 £205,473
March 31, 2024 £205,688 £238,038
March 31, 2023 £153,670 £77,654

Trustees

Name Appointed
Lesley Perkin (Chair) Feb. 2, 2024
Amanda Cordell May 6, 2022
Bernard McGrath May 6, 2022
David Cordell May 6, 2022
Mark Boulding May 6, 2022